AtriCure, Inc. (ATRC) vs Beam Therapeutics Inc. (BEAM)
A side-by-side comparison of AtriCure, Inc. and Beam Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRC
AtriCure, Inc.
$55.01HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
BEAM
Beam Therapeutics Inc.
$25.24HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — ATRC vs BEAM
growth of $100 · dividends reinvested · last 7yATRC +42.7% (+5.2%/yr)BEAM +36.9% (+4.6%/yr)ATRC compounded faster over this window
ATRC BEAM
ATRC vs BEAM: by the numbers
- •ATRC is the larger company ($2.80B vs $2.60B market cap).
- •ATRC is profitable (1.85% net margin) while BEAM runs a net loss (-54.75%).
- •BEAM grew revenue faster over the past five years (479.04% vs 18.57% CAGR).
Metrics side by side
Valuation
| Metric | ATRC | BEAM |
|---|---|---|
| P/E ratio | 259.22 | N/A |
| P/S ratio | 4.91 | 16.64 |
| P/B ratio | 5.42 | 2.43 |
| EV / EBITDA | 77.74 | N/A |
| FCF yield | 1.83% | N/A |
Profitability
| Metric | ATRC | BEAM |
|---|---|---|
| Gross margin | 76.16% | 84.05% |
| Operating margin | 2.44% | -274.57% |
| Net margin | 1.85% | -54.75% |
| ROE | 2.04% | -8.00% |
| ROIC | 2.04% | -28.96% |
Growth (annualized)
| Metric | ATRC | BEAM |
|---|---|---|
| Revenue CAGR (5Y) | 18.57% | 479.04% |
| Total return CAGR (5Y) | -4.06% | -21.41% |
Frequently asked
- Which has grown faster, ATRC or BEAM?
- Over the past five years, BEAM grew revenue faster — ATRC at a 18.57% CAGR versus BEAM at 479.04%.
- Is ATRC or BEAM more profitable?
- ATRC runs the higher net margin — ATRC at 1.85% versus BEAM at -54.75%.
- How have ATRC and BEAM total returns compared?
- Over the past 5 years, ATRC delivered -4.06% and BEAM delivered -21.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AtriCure P/E ratioAtriCure ROEBeam Therapeutics ROEAtriCure operating marginBeam Therapeutics operating marginAtriCure revenue growthBeam Therapeutics revenue growthAtriCure free cash flowBeam Therapeutics free cash flow
AtriCure & Beam Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.